New blood test targets hidden malaria to stop relapses
NCT ID NCT06923592
Summary
This large study is testing a new strategy to control a type of malaria that can hide in the liver and cause people to get sick again months later. In Ethiopia and Madagascar, researchers will use a new blood test to find people who were recently infected. Those who test positive will receive a targeted drug treatment aimed at killing the hidden parasites to prevent future malaria episodes. The goal is to see if this approach reduces malaria in the community over 18 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA, VIVAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Armauer Hansen Research Institute
NOT_YET_RECRUITINGAddis Ababa, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Pasteur de Madagascar
RECRUITINGAntananarivo, Madagascar
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.